previous compound ID: 688 next compound
InChIKey: GELRVIPPMNMYGS-RVXRQPKJSA-N
SMILES: C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4.Cl

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Goepp" "R Robert" "GW Carlile" "J Liao" "SD Macknight" "JW Hanrahan" "B Kus" "DY Thomas" "D Rotin" "E Matthes"

chemical graph of compound 688





CID is 62878
synonyms found at PubChem are:
Paroxetine hydrochloride, 78246-49-8, Paroxetine Hcl, Paroxat, Aropax 20, (3S,4R)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine hydrochloride, paroxetine (hydrochloride), BRL 29060 hydrochloride, UNII-3I3T11UD2S, 110429-35-1, Paroxetine hydrochloride [USP], BRL 29060A, SDB 7175, 3I3T11UD2S, HSDB 7175, S3005, C19H21ClFNO3, Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, hydrochloride, (3S,4R)-, Paroxetine hydrochloride hemihydrate (MW = 374.83), Paroxetine hydrochloride (USP), CHEMBL1708, (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine hydrochloride, (3S,4R)-3-[(2H-1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride, (-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-methylenedioxy)phenoxy)-methyl)piperidine hydrochloride, (3S-TRANS)-3-[(1,3-BENZODIOXOL-5-YLOXY)METHYL]-4-(4-FLUOROPHENYL)PIPERIDINE HYDROCHLORIDE, Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, hydrochloride, (3S-trans)-, 61869-08-7 (Parent), paroxatene, Paroxetine hydrochloride [USAN], BRL29060A, Paroxetine, HCl, paroxetine (Paxil), paroxetinehydrochloride, AC1L1XYV, C19H20FNO3.HCl, SCHEMBL33348, MLS002222322, PAROXETIN HYDROCHLORIDE, SPECTRUM1504085, CHEBI:7944, KS-00000JOT, DTXSID50228914, GELRVIPPMNMYGS-RVXRQPKJSA-N, MolPort-003-666-523, HMS1922B11, Pharmakon1600-01504085, (-)-trans-paroxetine hydrochloride, HY-B0492, Tox21_500095, ANW-49202, BG0380, CCG-39866, MFCD03658863, NSC758654, AKOS015849162, AKOS015907108, API0003757, CS-2611, H29P351, KS-5097, LP00095, NSC-758654, YF10047, NCGC00093597-01, NCGC00260780-01, AK-49032, AN-15600, BR-49032, SMR001307264, AB0008509, AB1004558, AX8022605, LS-114251, TC-137947, TL8005348, EU-0100095, P1977, ST24025708, D05374, J10285, Paroxetine or other medication - algorithm used, S-2491, 110429-35-1(hemihydrate) 61869-08-7, SR-01000759305, SR-01000759305-6, Z1741971218, (-)-trans-4-(-4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-piperidine hydrochloride, (-)-trans-4-(-4-fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)-piperidine hydrochloride, (-)-trans-4-(4-fluorophenyl)-3-(3,4-methylene dioxyphenoxymethyl)-piperidine hydrochloride, (3S,4R)-3-((BENZO[D][1,3]DIOXOL-5-YLOXY)METHYL)-4-(4-FLUOROPHENYL)PIPERIDINE HCL, (3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-piperidine hydrochloride, (-)TRANS-3-[(1,3-BENZODIOXOL-5-YLOXY) METHYL]-4-(4-FLUOROPHENYL) PAROXETINE HYDROCHLORIDE, (3S,4R)-(-)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine Hydrochloride, (3S,4R)-3-[(1,3-BENZODIOXOL-5-YLOXY)METHYL]-4-(4-FLUOROPHENYL)-PIPERIDINE HYDROCHLORIDE, (3S-trans)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride; Paroxetine Hydrochloride Anhydrous; (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine; 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl, (S)-3-(BENZO[1,3]DIOXOL-5-YLOXYMETHYL)-4-(4-FLUORO-PHENYL)-PIPERIDINE HYDROCHLORIDE, Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, hydrochloride,(3S-trans)-